INS and Insulin resistance: These changes were accompanied by decreased fasting plasma insulin levels and homeostatic model assessment of insulin resistance (HOMA-IR) (Figure 1, F and G), suggesting that myeloid ANT2 depletion improved systemic insulin sensitivity.